Searchable abstracts of presentations at key conferences in endocrinology

ea0063p981 | Diabetes, Obesity and Metabolism 3 | ECE2019

Effectiveness and tolerance of liraglutide and bupropión/naltrexone: clinical experience

Cardenas-Salas Jersy Jair , Luca Bogdana Luiza , Aliaga-Verdugo Alberto , Montoya-Alvarez Teresa , Gutierrez-Medina Sonsoles , Sierra-Poyatos Roberto , Sanz-Pastor Maria Alba Galdon , Martinez Clotilde Vazquez

Introduction: Different pharmacological therapies for obesity have become available in the last years. It is important to know their effectiveness in real-world practice and their acceptance among patients.Objectives: To analyze the anthropometric changes, daily dosis, side effects and treatment withdrawal in patients treated with Liraglutide or Naltrexone/Bupropion in clinical practice.Material and methods: Retrospective descripti...

ea0081p333 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

REAL Life study of SEMaglutide in Patients with Type 2 diabetes in SPain (REALSEM-SP): Retrospective clinical study on the efficacy, adherence, and safety with Semaglutide

Cardenas Salas Jersy Jair , Poyatos Roberto Miguel Sierra , Luiza Luca Bogdana , Sanchez Lechuga Begona , Modrono Mostoles Naiara , Montoya Alvarez Teresae , GoMez Montes Maria De La Paz , Sanchez-Lopez Raquel , Casado Carlos , Vazquez Martinez Clotilde

Introduction: Real-world data on glucose and weight control effectiveness in patients with Type 2 diabetes mellitus (T2DM) on treatment with semaglutide is scarce. We aim to assess it in a cohort of patients from a real-world setting in Spain.Materials and methods: We identified 830 patients with T2DM that were prescribed Semaglutide once-weekly since May 2019 to December 2020, in 4 hospitals in Madrid-Spain. At 6±3 months, 435 GPL1-naïve and 3...